All Search Results
-
About Us
Orlando Health Arnold Palmer Hospital for Children and Orlando Health Winnie Palmer Hospital for Women & Babies is the largest facility dedicated to children and women in the United States. We have many strengths that make us a leader in women's healthcare. Among them:
-
Get to Know Dr Xiomara Santos
It’s not very often that we have time to get to know the doctors who take care of us. They’re busy, and we’re focused on whatever issue has brought us to them as a patient. But sometimes it’s helpful to be reminded that the doctors who take care of us are people just like us, and it’s fun to get to know them on a more personal level.
-
What do you do when your child just won't cooperate with getting clean?
What do you do if your child does not cooperate with hygiene tasks? Should you battle it out? Just let it go? Of all the tasks a parent must help their child with during a day, these can be the most challenging for parents and kids. They are often the “you have to” tasks for parents and the “I won’t” kind of tasks for the child.
-
Do You Know What to do if Your Child is Choking?
It is the nightmare scenario that can send any parent into a cold sweat: what if my child is choking and I don’t know how to help him?
-
A Study Testing the Combo of Dasatinib or Imatinib to Chemo Treatment W/ Blinatumomab for Children, Adolescents, & YA W/ Ph+ or Ph-Like B-cell B-ALL
An International Phase 2 Study of Chemotherapy and Tyrosine Kinase Inhibitors with Blinatumomab in Patients with Newly-Diagnosed Philadelphia Chromosome-Positive or ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
-
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination With Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged ≥1 to <31 Years Old With First Relapse
-
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
-
What to do when your new baby is crying
Being a parent for the first time is an exciting adventure, with many moments of joy but certainly also many moments of anxiety when facing the unknown, whether it be feeding techniques, putting a baby to sleep, etc. Parents often talk about their baby being fussy, or crying. It’s a common parental concern raised at office visits and is one worthy of delving into, as it could be a sign of something common or that something may be very wrong.
-
Get to Know Clinical Geneticist, Dr. Ingrid Cristian
Clinical genetics is an area of medicine you may not be very familiar with, but it’s a rapidly evolving discipline that offers us much-needed clues about the how and why of disease.
-
Getting to Know Dr. Celine Cattier, Pediatric Palliative Care Specialist
Today we’ll get to know Dr. Celine Cattier, a pediatric palliative care specialist, who has recently joined the Pediatric Palliative Care Team alongside Dr. Blaine Pitts to offer services to patients from newborn to young adult at Arnold Palmer Hospital and Winnie Palmer Hospital.
